Bioorganic & Medicinal Chemistry

Papers
(The H4-Index of Bioorganic & Medicinal Chemistry is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Synthesis and antiproliferative activity of (−)-cleistenolide, (6S)-cleistenolide and 4-substituted cleistenolide analogues101
Synthesis and biological evaluation of pyrazole-fused oleanolic acid derivatives as novel inhibitors of inflammatory and osteoclast differentiation88
Novel hybrid conjugates with dual estrogen receptor α degradation and histone deacetylase inhibitory activities for breast cancer therapy79
Production and synthesis of a novel 191Pt-labeled platinum complex and evaluation of its biodistribution in healthy mice78
Crescent-shaped meta-substituted benzene derivatives as a new class of non-nucleoside ribonuclease A inhibitors64
A DNA-encoded library special issue57
Discovery of novel 2,8-diazaspiro[4.5]decan-1-one derivatives as potent RIPK1 kinase inhibitors55
Sustainable electrochemical C(sp3) − H oxygenation using water as the oxygen source46
Targeting prolidase. A survey of the literature data to depict a structure-activity relationship frame and to address future studies for drug development42
Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents42
Multiple approaches to repurposing drugs for neuroblastoma37
Current Japanese pharmaceutical chemistry36
Design, synthesis and evaluation the bioactivities of novel 1,3-dimethyl-6-amino-1H-indazole derivatives as anticancer agents36
Graphical abstract TOC35
Contents continued34
Editorial Board33
Diterpenoids from the whole plants of Croton yunnanensis and their bioactivities33
Graphical abstract TOC33
Development of delivery carriers for plasmid DNA by conjugation of a helical template to oligoarginine33
Design, synthesis and antibacterial evaluation of oxazolidinone derivatives containing N-methylglycyl or quaternary ammonium salts33
Selective targeting of human TET1 by cyclic peptide inhibitors: Insights from biochemical profiling32
Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors32
Targeting m6A binding protein YTHDFs for cancer therapy32
RNA-templated chemical synthesis of proapoptotic L- and d-peptides31
Synthesis and medicinal chemistry of tetronamides: Promising agrochemicals and antitumoral compounds31
Exploring novel A2AAR antagonists: Design, synthesis, and evaluation of 2,6,9-trisubstituted purine derivatives as promising antifibrotic agents31
DNA-encoded C H functionality via photoredox-mediated hydrogen atom transformation catalysis30
Site-specific construction of triptolide-based antibody-drug conjugates30
Design, synthesis and validation of a new Crimped Head-Piece for DNA-Encoded libraries generation30
Research progress of STAT3-based dual inhibitors for cancer therapy30
0.061751127243042